Skip to main content
Top
Published in: BMC Gastroenterology 1/2019

Open Access 01-12-2019 | Obesity | Research article

What is the impact of metabolic syndrome and its components on reflux esophagitis? A cross-sectional study

Authors: Yi-Hsuan Hsieh, Mei-Fong Wu, Pei-Yu Yang, Wei-Cheng Liao, Yao-Hsuan Hsieh, Yu-Jun Chang, I-Ching Lin

Published in: BMC Gastroenterology | Issue 1/2019

Login to get access

Abstract

Background

The prevalence rate of reflux esophagitis (RE) in Asia, including Taiwan, has increased dramatically in recent years. However, few studies have discussed on its relationship with metabolic syndrome (MetS). This study aimed to evaluate the correlation between RE and MetS and its components.

Methods

We conducted a cross-sectional study during 2013 to 2014 in Taiwan. A total of 4895 subjects who completed upper gastrointestinal endoscopy at the Health Examination Center of Changhua Christian Hospital were enrolled. RE was defined according to the upper gastrointestinal endoscopic findings and MetS was defined according to the Taiwanese criteria. Univariate and multivariate logistic regression analyses were applied to calculate odds ratios and 95% confidence intervals for each variable to assess the associated features for RE. We analyzed the relationship between the number of MetS components and the severity of RE using the chi-square test for trend.

Results

The prevalence rates of MetS and RE were respectively 28.5 and 59.6%. According to univariate logistic regression analysis, MetS was significantly associated with RE and remained a positive association in multivariate logistic regression analysis (adjusted ORß = 1.251; 95% CI = 1.071–1.462; p = 0.005). Furthermore, among the five MetS components, elevated blood pressure (adjusted ORγ = 1.163; 95% CI = 1.023–1.323; p = 0.021), abdominal obesity (adjusted ORγ = 1.173; 95% CI = 1.020–1.349; p = 0.026) and hyperglycemia (adjusted ORγ = 1.306; 95% CI = 1.142–1.495; p < 0.001) were positively associated with the presence of RE. A weak association was also found between elevated triglycerides and RE after adjusting for age and gender (adjusted ORα = 1.171; 95% CI = 1.022–1.343; p = 0.023). Reduced high-density lipoprotein cholesterol showed no significant difference between groups with and without RE. Older age (≥65 years), male gender, higher body mass index, higher uric acid, smoking, alcohol drinking, and hiatal hernia were found to be significant associated factors for RE. In addition, a dose-response relation between the number of MetS components and the presence of RE was demonstrated in the multivariate analysis. Furthermore, we performed a trend analysis and found the severity of RE got worse as the number of MetS components increased (p < 0.001).

Conclusion

This study suggests that MetS is significantly related to the presence and the severity of RE.
Literature
1.
go back to reference Kang JY, Tay HH, I Y, Guan R, Lim KP, Math MV. Low frequency of endoscopic esophagitis in Asian patients. J Clin Gastroenterol. 1993;16(1):70–3.CrossRef Kang JY, Tay HH, I Y, Guan R, Lim KP, Math MV. Low frequency of endoscopic esophagitis in Asian patients. J Clin Gastroenterol. 1993;16(1):70–3.CrossRef
2.
go back to reference Goh KL. Gastroesophageal reflux disease in Asia: a historical perspective and present challenges. J Gastroenterol Hepatol. 2011;26(Suppl 1):2–10.CrossRef Goh KL. Gastroesophageal reflux disease in Asia: a historical perspective and present challenges. J Gastroenterol Hepatol. 2011;26(Suppl 1):2–10.CrossRef
3.
go back to reference Nasseri-Moghaddam S, Razjouyan H, Alimohamadi SM, Mamarabadi M, Ghotbi MH, Mostajabi P, Sohrabpour AA, Sotoudeh M, Abedi B, Mofid A, et al. Prospective acid reflux study of Iran (PARSI): methodology and study design. BMC Gastroenterol. 2007;7:42.CrossRef Nasseri-Moghaddam S, Razjouyan H, Alimohamadi SM, Mamarabadi M, Ghotbi MH, Mostajabi P, Sohrabpour AA, Sotoudeh M, Abedi B, Mofid A, et al. Prospective acid reflux study of Iran (PARSI): methodology and study design. BMC Gastroenterol. 2007;7:42.CrossRef
4.
go back to reference Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus G. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900–20 quiz 1943.CrossRef Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus G. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900–20 quiz 1943.CrossRef
5.
go back to reference Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308–28 quiz 329.CrossRef Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308–28 quiz 329.CrossRef
6.
go back to reference Ierardi E, Rosania R, Zotti M, Principe S, Laonigro G, Giorgio F, de Francesco V, Panella C. Metabolic syndrome and gastro-esophageal reflux: a link towards a growing interest in developed countries. World J Gastrointest Pathophysiol. 2010;1(3):91–6.CrossRef Ierardi E, Rosania R, Zotti M, Principe S, Laonigro G, Giorgio F, de Francesco V, Panella C. Metabolic syndrome and gastro-esophageal reflux: a link towards a growing interest in developed countries. World J Gastrointest Pathophysiol. 2010;1(3):91–6.CrossRef
7.
go back to reference Dodds WJ, Hogan WJ, Helm JF, Dent J. Pathogenesis of reflux esophagitis. Gastroenterology. 1981;81:376–94.PubMed Dodds WJ, Hogan WJ, Helm JF, Dent J. Pathogenesis of reflux esophagitis. Gastroenterology. 1981;81:376–94.PubMed
8.
go back to reference Lenglinger J, Riegler M, Schoppmann SF. Gastroesophageal reflux disease and metabolic syndrome. Intern Med. 2012;51(20):2993–3. Lenglinger J, Riegler M, Schoppmann SF. Gastroesophageal reflux disease and metabolic syndrome. Intern Med. 2012;51(20):2993–3.
9.
go back to reference Moki F, Kusano M, Mizuide M, Shimoyama Y, Kawamura O, Takagi H, Imai T, Mori M. Association between reflux oesophagitis and features of the metabolic syndrome in Japan. Aliment Pharmacol Ther. 2007;26(7):1069–75.CrossRef Moki F, Kusano M, Mizuide M, Shimoyama Y, Kawamura O, Takagi H, Imai T, Mori M. Association between reflux oesophagitis and features of the metabolic syndrome in Japan. Aliment Pharmacol Ther. 2007;26(7):1069–75.CrossRef
10.
go back to reference Ze EY, Kim BJ, Kang H, Kim JG. Abdominal visceral to subcutaneous adipose tissue ratio is associated with increased risk of erosive esophagitis. Dig Dis Sci. 2017;62(5):1265–71.CrossRef Ze EY, Kim BJ, Kang H, Kim JG. Abdominal visceral to subcutaneous adipose tissue ratio is associated with increased risk of erosive esophagitis. Dig Dis Sci. 2017;62(5):1265–71.CrossRef
11.
go back to reference Niigaki M, Adachi K, Hirakawa K, Furuta K, Kinoshita Y. Association between metabolic syndrome and prevalence of gastroesophageal reflux disease in a health screening facility in Japan. J Gastroenterol. 2013;48(4):463–72.CrossRef Niigaki M, Adachi K, Hirakawa K, Furuta K, Kinoshita Y. Association between metabolic syndrome and prevalence of gastroesophageal reflux disease in a health screening facility in Japan. J Gastroenterol. 2013;48(4):463–72.CrossRef
12.
go back to reference Mohammadi M, Ramezani Jolfaie N, Alipour R, Zarrati M. Is metabolic syndrome considered to be a risk factor for gastroesophageal reflux disease (non-erosive or erosive esophagitis)?: a systematic review of the evidence. Iran Red Crescent Med J. 2016;18(11):e30363.CrossRef Mohammadi M, Ramezani Jolfaie N, Alipour R, Zarrati M. Is metabolic syndrome considered to be a risk factor for gastroesophageal reflux disease (non-erosive or erosive esophagitis)?: a systematic review of the evidence. Iran Red Crescent Med J. 2016;18(11):e30363.CrossRef
13.
go back to reference Wong BC, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol. 2006;4(4):398–407.CrossRef Wong BC, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol. 2006;4(4):398–407.CrossRef
14.
go back to reference Goh KL. Obesity and increasing gastroesophageal reflux disease in Asia. J Gastroenterol Hepatol. 2007;22(10):1557–8.CrossRef Goh KL. Obesity and increasing gastroesophageal reflux disease in Asia. J Gastroenterol Hepatol. 2007;22(10):1557–8.CrossRef
15.
go back to reference Lee YC, Yen AM, Tai JJ, Chang SH, Lin JT, Chiu HM, Wang HP, Wu MS, Chen TH. The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease. Gut. 2009;58(2):174–81.CrossRef Lee YC, Yen AM, Tai JJ, Chang SH, Lin JT, Chiu HM, Wang HP, Wu MS, Chen TH. The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease. Gut. 2009;58(2):174–81.CrossRef
16.
go back to reference El-Serag HB, Ergun GA, Pandolfino J, Fitzgerald S, Tran T, Kramer JR. Obesity increases oesophageal acid exposure. Gut. 2007;56(6):749–55.CrossRef El-Serag HB, Ergun GA, Pandolfino J, Fitzgerald S, Tran T, Kramer JR. Obesity increases oesophageal acid exposure. Gut. 2007;56(6):749–55.CrossRef
17.
go back to reference Watanabe S, Hojo M, Nagahara A. Metabolic syndrome and gastrointestinal diseases. J Gastroenterol. 2007;42(4):267–74.CrossRef Watanabe S, Hojo M, Nagahara A. Metabolic syndrome and gastrointestinal diseases. J Gastroenterol. 2007;42(4):267–74.CrossRef
18.
go back to reference Chung SJ, Kim D, Park MJ, Kim YS, Kim JS, Jung HC, Song IS. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut. 2008;57(10):1360–5.CrossRef Chung SJ, Kim D, Park MJ, Kim YS, Kim JS, Jung HC, Song IS. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut. 2008;57(10):1360–5.CrossRef
19.
go back to reference Loke SS, Yang KD, Chen KD, Chen JF. Erosive esophagitis associated with metabolic syndrome, impaired liver function, and dyslipidemia. World J Gastroenterol. 2013;19(35):5883–8.CrossRef Loke SS, Yang KD, Chen KD, Chen JF. Erosive esophagitis associated with metabolic syndrome, impaired liver function, and dyslipidemia. World J Gastroenterol. 2013;19(35):5883–8.CrossRef
20.
go back to reference Tai CM, Lee YC, Tu HP, Huang CK, Wu MT, Chang CY, Lee CT, Wu MS, Lin JT, Wang WM. The relationship between visceral adiposity and the risk of erosive esophagitis in severely obese Chinese patients. Obesity (Silver Spring). 2010;18(11):2165–9.CrossRef Tai CM, Lee YC, Tu HP, Huang CK, Wu MT, Chang CY, Lee CT, Wu MS, Lin JT, Wang WM. The relationship between visceral adiposity and the risk of erosive esophagitis in severely obese Chinese patients. Obesity (Silver Spring). 2010;18(11):2165–9.CrossRef
21.
go back to reference Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112(17):2735–52.CrossRef Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112(17):2735–52.CrossRef
22.
go back to reference International Diabetes Federation. The IDF Consensus worldwide definition of the metabolic syndrome. 2006. International Diabetes Federation. The IDF Consensus worldwide definition of the metabolic syndrome. 2006.
23.
go back to reference Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodes-Cabau J, Bertrand OF, Poirier P. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28(6):1039–49.CrossRef Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodes-Cabau J, Bertrand OF, Poirier P. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28(6):1039–49.CrossRef
24.
go back to reference Park JH, Park DIL, Kim HJ, Cho YK, Sohn CIL, Jeon WK, Kim BI. Metabolic syndrome is associated with erosive esophagitis. World J Gastroenterol. 2008;14(35):5442–7.CrossRef Park JH, Park DIL, Kim HJ, Cho YK, Sohn CIL, Jeon WK, Kim BI. Metabolic syndrome is associated with erosive esophagitis. World J Gastroenterol. 2008;14(35):5442–7.CrossRef
25.
go back to reference Wu P, Ma L, Dai GX, Chen Y, Tong YL, Wang C, Yao LW, Jiang YX, Xu SC, Ai ZS. The association of metabolic syndrome with reflux esophagitis: a case-control study. Neurogastroenterol Motil. 2011;23(11):989–94.CrossRef Wu P, Ma L, Dai GX, Chen Y, Tong YL, Wang C, Yao LW, Jiang YX, Xu SC, Ai ZS. The association of metabolic syndrome with reflux esophagitis: a case-control study. Neurogastroenterol Motil. 2011;23(11):989–94.CrossRef
26.
go back to reference Lee SW, Lien HC, Chang CS, Lee TY, Peng YC, Yeh HZ. Association of metabolic syndrome with erosive esophagitis and Barrett's esophagus in a Chinese population. J Chin Med Assoc. 2017;80(1):15–8.CrossRef Lee SW, Lien HC, Chang CS, Lee TY, Peng YC, Yeh HZ. Association of metabolic syndrome with erosive esophagitis and Barrett's esophagus in a Chinese population. J Chin Med Assoc. 2017;80(1):15–8.CrossRef
27.
go back to reference Sogabe M, Okahisa T, Kimura T, Okamoto K, Miyamoto H, Muguruma N, Takayama T. Influence of metabolic syndrome on upper gastrointestinal disease. Clin J Gastroenterol. 2016;9(4):191–202.CrossRef Sogabe M, Okahisa T, Kimura T, Okamoto K, Miyamoto H, Muguruma N, Takayama T. Influence of metabolic syndrome on upper gastrointestinal disease. Clin J Gastroenterol. 2016;9(4):191–202.CrossRef
28.
go back to reference World Health Organization. Waist circumference and waist–hip ratio: report of a WHO expert consultation. Geneva: World Health Organization; 2008. World Health Organization. Waist circumference and waist–hip ratio: report of a WHO expert consultation. Geneva: World Health Organization; 2008.
29.
go back to reference Armstrong D, Bennett JR, Blum AL, Dent J, Dombal FTD, Galmiche JP, Lundell L, Margulies M, Richter JE, Spechler SJ, et al. The endoscopic assessment of esophagitis: a Progress report on observer agreement. Gastroenterology. 1996;111:85–92.CrossRef Armstrong D, Bennett JR, Blum AL, Dent J, Dombal FTD, Galmiche JP, Lundell L, Margulies M, Richter JE, Spechler SJ, et al. The endoscopic assessment of esophagitis: a Progress report on observer agreement. Gastroenterology. 1996;111:85–92.CrossRef
30.
go back to reference Song HJ, Shim KN, Yoon SJ, Kim SE, Oh HJ, Ryu KH, Ha CY, Yeom HJ, Song JH, Jung SA, et al. The prevalence and clinical characteristics of reflux esophagitis in koreans and its possible relation to metabolic syndrome. J Korean Med Sci. 2009;24(2):197–202.CrossRef Song HJ, Shim KN, Yoon SJ, Kim SE, Oh HJ, Ryu KH, Ha CY, Yeom HJ, Song JH, Jung SA, et al. The prevalence and clinical characteristics of reflux esophagitis in koreans and its possible relation to metabolic syndrome. J Korean Med Sci. 2009;24(2):197–202.CrossRef
31.
go back to reference Gudlaugsdottira S, Verschuren WMM, Dees J, Stijnen T, Wilsona JHP. Hypertension is frequently present in patients with reflux esophagitis or Barrett’s esophagus but not in those with non-ulcer dyspepsia. Eur J Intern Med. 2002;13:369–75.CrossRef Gudlaugsdottira S, Verschuren WMM, Dees J, Stijnen T, Wilsona JHP. Hypertension is frequently present in patients with reflux esophagitis or Barrett’s esophagus but not in those with non-ulcer dyspepsia. Eur J Intern Med. 2002;13:369–75.CrossRef
32.
go back to reference Chua CS, Lin YM, Yu FC, Hsu YH, Chen JH, Yang KC, Shih CH. Metabolic risk factors associated with erosive esophagitis. J Gastroenterol Hepatol. 2009;24(8):1375–9.CrossRef Chua CS, Lin YM, Yu FC, Hsu YH, Chen JH, Yang KC, Shih CH. Metabolic risk factors associated with erosive esophagitis. J Gastroenterol Hepatol. 2009;24(8):1375–9.CrossRef
33.
go back to reference Rayner CK, Samsom M, Jones KL, Horowitz M. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care. 2001;24:371–81.CrossRef Rayner CK, Samsom M, Jones KL, Horowitz M. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care. 2001;24:371–81.CrossRef
34.
go back to reference Fraser R, Horowitz M, Dent J. Hyperglycaemia stimulates pyloric motility in normal subjects. Gut. 1991;32:475–8.CrossRef Fraser R, Horowitz M, Dent J. Hyperglycaemia stimulates pyloric motility in normal subjects. Gut. 1991;32:475–8.CrossRef
35.
go back to reference Hsu CS, Wang PC, Chen JH, Su WC, Tseng TC, Chen HD, Hsiao TH, Wang CC, Lin HH, Shyu RY, et al. Increasing insulin resistance is associated with increased severity and prevalence of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2011;34(8):994–1004.CrossRef Hsu CS, Wang PC, Chen JH, Su WC, Tseng TC, Chen HD, Hsiao TH, Wang CC, Lin HH, Shyu RY, et al. Increasing insulin resistance is associated with increased severity and prevalence of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2011;34(8):994–1004.CrossRef
36.
go back to reference Chang CH, Wu CP, Wang JD, Lee SW, Chang CS, Yeh HZ, Ko CW, Lien HC. Alcohol and tea consumption are associated with asymptomatic erosive esophagitis in Taiwanese men. PLoS One. 2017;12(3):e0173230.CrossRef Chang CH, Wu CP, Wang JD, Lee SW, Chang CS, Yeh HZ, Ko CW, Lien HC. Alcohol and tea consumption are associated with asymptomatic erosive esophagitis in Taiwanese men. PLoS One. 2017;12(3):e0173230.CrossRef
Metadata
Title
What is the impact of metabolic syndrome and its components on reflux esophagitis? A cross-sectional study
Authors
Yi-Hsuan Hsieh
Mei-Fong Wu
Pei-Yu Yang
Wei-Cheng Liao
Yao-Hsuan Hsieh
Yu-Jun Chang
I-Ching Lin
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2019
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-019-0950-z

Other articles of this Issue 1/2019

BMC Gastroenterology 1/2019 Go to the issue